Publicaciones en las que colabora con PABLO ALVAREZ ARANEGA (44)

2016

  1. Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results

    Oxidative Medicine and Cellular Longevity, Vol. 2016

  2. Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells

    Archives of Medical Science, Vol. 12, Núm. 5, pp. 919-927

2015

  1. Cancer stem-cells patents in the context of their therapeutic purposes: Exploring the latest trends (2011-2015)

    Recent Patents on Regenerative Medicine, Vol. 5, Núm. 1, pp. 55-64

  2. Computer tools and collaborative translational research in the life sciences: The further advance of genomics and proteomics

    European Journal of Anatomy, Vol. 19, Núm. 2, pp. 131-137

  3. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

2014

  1. ABC transporters as differentiation markers in glioblastoma cells

    Molecular Biology Reports, Vol. 41, Núm. 8, pp. 4847-4851

  2. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: Review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Núm. 1, pp. 21-34

  3. Cancer stem cells and their implication in breast cancer

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 678-687

  4. Erratum: A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin (BioDrugs DOI : 10.1007/s40259-013-0055-0)

    BioDrugs

  5. Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?

    Journal of Mammary Gland Biology and Neoplasia, Vol. 19, Núm. 3-4, pp. 303-313

  6. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo

    European Journal of Medicinal Chemistry, Vol. 79, pp. 1-12

  7. Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

    Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720

2013

  1. Antitumor properties of natural compounds and related molecules

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 203-215

  2. Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 13, Núm. 8, pp. 1204-1216

  3. Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance

    Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541

  4. Predictive value of stabilometry and fear of falling on falls in postmenopausal women

    Climacteric, Vol. 16, Núm. 5, pp. 584-589

  5. RNA interference in the treatment of colon cancer

    BioDrugs, Vol. 27, Núm. 4, pp. 317-327

  6. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing

    BioMed Research International, Vol. 2013

  7. Relationship of body mass index and body fat distribution with postural balance and risk of falls in Spanish postmenopausal women

    Menopause, Vol. 20, Núm. 2, pp. 202-208

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107